News & Views | Published:

Raising the bar for cancer therapy models

Nature Biotechnology volume 28, pages 561562 (2010) | Download Citation

Can mouse cancer models predict the results of phase 3 clinical trials?

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Nat. Rev. Drug Discov. 3, 711–715 (2004).

  2. 2.

    et al. N. Engl. J. Med. 355, 2542–2550 (2006).

  3. 3.

    et al. Curr. Drug Discov. Technol. 6, 91–102 (2009).

  4. 4.

    et al. Nat. Biotechnol. 28, 585–593 (2010).

  5. 5.

    Cancer Biol. Ther. 2, 108–113 (2003).

  6. 6.

    & Nat. Rev. Cancer 7, 645–658 (2007).

  7. 7.

    , , & Am. J. Pathol. 170, 793–804 (2007).

  8. 8.

    & Eur. J. Cancer 40, 837–844 (2004).

  9. 9.

    et al. Cancer 64, 1577–1582 (1989).

  10. 10.

    et al. Cancer Cell 15, 232–239 (2009).

  11. 11.

    et al. Cancer Res. 66, 3386–3391 (2006).

  12. 12.

    et al. Clin. Cancer Res. 15, 6358–6366 (2009).

Download references

Acknowledgements

We thank U. Emmenegger as well as members of the Kerbel Lab, in particular C. Hackl, C. Milsom and W. Cruz-Munoz, for their comments and suggestions.

Author information

Affiliations

  1. Giulio Francia and Robert S. Kerbel are in Molecular & Cellular Biology Research, Sunnybrook Health Science Centre, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

    • Giulio Francia
    •  & Robert S Kerbel

Authors

  1. Search for Giulio Francia in:

  2. Search for Robert S Kerbel in:

Competing interests

R.S.K. is a member of the scientific advisory board of VisualSonics, Inc., Toronto, which manufactures ultrasound imaging equipment for small animal research.

Corresponding authors

Correspondence to Giulio Francia or Robert S Kerbel.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0610-561

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing